EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

E-cigarettes for tobacco harm reduction in older adults who fail tobacco cessation treatment offered at lung cancer screening: a pilot trial

E-Zigaretten zur Schadensminderung bei älteren Erwachsenen, die nach einem Tabakentwöhnungsangebot beim Lungenkrebsscreening nicht aufhören konnten: Pilotstudie

Jaqueline C Avila iD, Olufemi Erinoso iD, Nirotma Tripathi, Josephine Boateng, Connor Triehy, Caylin Marotta, Caitlin McCann, Michele Reyen, Susan Regan, Jennifer S Haas, Elyse R Park iD, Nancy A Rigotti

Nicotine & Tobacco Research · 30.05.2026

DOI: 10.1093/ntr/ntag085 ↗

Auf einen Blick

In einer Pilotstudie mit 15 älteren Erwachsenen war die Bereitstellung von E-Zigaretten machbar. Zigarettenkonsum und Atem-CO nahmen über 4 Wochen ab.

Fragestellung

Ist die Bereitstellung von E-Zigaretten bei älteren Erwachsenen, die nach einem Tabakentwöhnungsprogramm beim Lungenkrebsscreening weiter rauchen, machbar und mit kurzfristigen Effekten verbunden?

Methode

Pilotstudie mit Mixed-Methods und Single-Arm-Design; ältere Erwachsene nach abgeschlossener Rauchentwöhnungsstudie beim Lungenkrebsscreening; NJOY Ace E-Zigarette mit 5 % Nikotin für 4 Wochen; Assessments bis Woche 8.

Ergebnisse

15 Teilnehmende wurden eingeschlossen, 14 schlossen ab. CPD sank von 16,9 (SD 7,2) auf 10,4 (SD 7,0; P<.001), Atem-CO von 19,4 (SD 11,0) auf 12,3 (SD 8,5; P=.04).

Schlussfolgerung der Autor:innen

Die Pilotstudie zeigte die Machbarkeit der Rekrutierung und deutet auf eine kurzfristige Wirksamkeit zur Reduktion von Zigarettenkonsum und CO-Exposition hin.

Kernaussagen

  • 15 Teilnehmende, 14 schlossen die Studie ab
  • CPD und Atem-CO sanken über 4 Wochen
  • Die meisten wurden zu Dual-Usern von E-Zigarette und Zigarette

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Fachartikel in der Zeitschrift Nicotine & Tobacco Research, online erschienen am 30.05.2026. Verfasst von Jaqueline C Avila und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gerontology, Manning College of Nursing and Health Sciences, University of Massachusetts Boston, Boston, MA 02125, United States. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NIH HHS, National Cancer Institute.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Lung cancer screening (LCS) is an optimal time to offer tobacco treatment to adults who smoke, but many cannot quit even with treatment. Replacing combustible cigarettes (CC) with e-cigarettes (EC) could be a harm reduction approach, but few older adults use EC. No study has examined EC harm reduction potential among individuals undergoing LCS.

Methods

In a pilot mixed-methods single-arm clinical trial, we assessed the feasibility and short-term effects of providing EC to older adults not planning to quit after completing a smoking cessation trial at LCS. Participants were asked to use tobacco-flavored NJOY Ace EC (5% nicotine) for 4 weeks. Assessments occurred at weeks 1, 2, 3, 4, and 8, with qualitative interviews at week 4. Primary outcomes were study feasibility and change in cigarettes/day (CPD) during EC provision. Secondary outcomes included breath carbon monoxide (CO) and EC use.

Results

From 9/2024–2/2025, we enrolled 15 participants (54% of eligibles; mean age = 66.1 years, 40% female); 14 (93%) completed the study. Over the 4-week EC provision, mean CPD and breath CO declined significantly (CPD = 16.9 [SD:7.2] to 10.4[SD: 7.0], P<.001; CO: 19.4[SD:11.0] to 12.3[SD: 8.5], P=.04). Mean CPD remained stable post-EC provision. At week 4, participants used EC on 5.5 (SD:2.4) days/week; 2 participants (13%) used only EC, 12 (80%) were dual users, and 1 (7%) used only CC.

Conclusions

This pilot trial showed the feasibility of recruiting older adults unable to quit smoking after LCS to use EC and suggested the short-term efficacy of EC to reduce CC consumption and CO exposure.

Implications

This pilot study demonstrates the feasibility and promising short-term effects of switching older adults who smoke and did not quit at LCS to use EC. Participants’ cigarette consumption and CO exposure declined over 4 weeks of EC provision, but most participants became dual users (EC and CC). Qualitative interviews illustrated benefits and challenges of switching. The findings deserve confirmation in a larger sample, but suggest that longer EC provision and behavioral support might help this group to completely replace CC use and gain the full harm reduction benefits associated with switching to EC.

Schlagwörter

Stichwörter der Autor:innen

electronic cigaretteslung cancer screeningolder adults

Autor:innen und Institutionen

  • Department of Gerontology, Manning College of Nursing and Health Sciences, University of Massachusetts Boston, Boston, MA 02125, United States.
  • Tobacco Research and Treatment Center, Department of Medicine and Mongan Institute, Massachusetts General Hospital, Boston, MA 02114, United States.
  • Center for Addiction Medicine, Massachusetts General Hospital, Boston, MA 02114, United States.
  • Boston University School of Public Health, Boston, MA 02118, United States.
  • Department of Medicine, Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA 02114, United States.
  • Department of Psychology, College of Liberal Arts, University of Massachusetts Boston, Boston, MA 02125, United States.

ORCID-Profile: Jaqueline C Avila, Olufemi Erinoso, Elyse R Park

Förderung

  • NCI NIH HHS
  • NIH HHS
  • National Cancer Institute
  • National Institutes of Health

Zitieren

APA

Avila, J. C., Erinoso, O., Tripathi, N., Boateng, J., Triehy, C., Marotta, C., McCann, C., Reyen, M., Regan, S., Haas, J. S., Park, E. R., & Rigotti, N. A. (2026). E-cigarettes for tobacco harm reduction in older adults who fail tobacco cessation treatment offered at lung cancer screening: a pilot trial. Nicotine & Tobacco Research. https://doi.org/10.1093/ntr/ntag085

Vancouver

Avila JC, Erinoso O, Tripathi N, Boateng J, Triehy C, Marotta C, et al. E-cigarettes for tobacco harm reduction in older adults who fail tobacco cessation treatment offered at lung cancer screening: a pilot trial. Nicotine & Tobacco Research. 2026. doi:10.1093/ntr/ntag085

BibTeX
@article{Avila2026,
  author = {Avila, Jaqueline C and Erinoso, Olufemi and Tripathi, Nirotma and Boateng, Josephine and Triehy, Connor and Marotta, Caylin and McCann, Caitlin and Reyen, Michele and Regan, Susan and Haas, Jennifer S and Park, Elyse R and Rigotti, Nancy A},
  title = {E-cigarettes for tobacco harm reduction in older adults who fail tobacco cessation treatment offered at lung cancer screening: a pilot trial},
  journal = {Nicotine & Tobacco Research},
  year = {2026},
  doi = {10.1093/ntr/ntag085}
}
Kostenlos starten →